Skip to main content
Clinical Trials/IRCT20200915048726N2
IRCT20200915048726N2
Not yet recruiting
Phase 2

The effect of probiotics in the treatment of patients with halitosis

Mazandaran University of Medical Sciences0 sites47 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mazandaran University of Medical Sciences
Enrollment
47
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age range from 18 to 60 years
  • Halitosis with an Organoleptic (OLT) score of two and above, which is subjectively determined by the doctor and objectively by the person herself
  • Informed consent

Exclusion Criteria

  • The presence of infection and active inflammation of the nose and pharynx in examination and history
  • History of sensitivity to probiotics
  • The presence of infection and active inflammation of the mouth and teeth in examination and history
  • Advanced renal failure
  • Cirrhosis of the liver
  • The patient's lack of consent to participate or the desire to withdraw from the study
  • Use of immunosuppressive drugs
  • Pregnancy and breastfeeding
  • Use of mouthwash and mouth fresheners during the study
  • Patients with typical symptoms GERD or peptic ulcer

Outcomes

Primary Outcomes

Not specified

Similar Trials